Cargando…

Efficacy and Safety of Liver Resection in Super Elderly Patients with Hepatocellular Carcinoma

OBJECTIVE: Liver resection in the super elderly patients remains challenging because of comorbidities and operative tolerability. METHODS: In this study, we compared postoperative complications and survival in patients aged ≥85 yr included five patients aged ≥90 yr with those aged 70-79 and 80-84 yr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Hidekazu, Kaibori, Masaki, Matsushima, Hideyuki, Kosaka, Hisashi, Matsui, Kosuke, Sekimoto, Mitsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334108/
https://www.ncbi.nlm.nih.gov/pubmed/36974565
http://dx.doi.org/10.31557/APJCP.2023.24.3.1089
_version_ 1785070797462700032
author Yamamoto, Hidekazu
Kaibori, Masaki
Matsushima, Hideyuki
Kosaka, Hisashi
Matsui, Kosuke
Sekimoto, Mitsugu
author_facet Yamamoto, Hidekazu
Kaibori, Masaki
Matsushima, Hideyuki
Kosaka, Hisashi
Matsui, Kosuke
Sekimoto, Mitsugu
author_sort Yamamoto, Hidekazu
collection PubMed
description OBJECTIVE: Liver resection in the super elderly patients remains challenging because of comorbidities and operative tolerability. METHODS: In this study, we compared postoperative complications and survival in patients aged ≥85 yr included five patients aged ≥90 yr with those aged 70-79 and 80-84 yr at a single institution. RESULTS: Three hundred sixty-seven patients aged ≥70 yr underwent liver resection and were divided into three groups based on age at operation between 2010 and 2022; (a) 70-79 yr (median of 74 yr, n=245), (b) 80-84 yr (median of 82 yr, n=81), and (c) ≥85 yr (median of 87 yr, n=41). In the ≥85 yr group (90-yr-old group), twenty-five patients (four) had hypertension, fourteen (one) had diabetes mellitus, seven (one) had cardiovascular disease, and five patients (one) had dementia. The rate of comorbidities did not differ significantly among three groups. The rate of postoperative complications (Clavien–Dindo grade 3a≤) was 25% in the 70- to 79-yr-old group, 27% in the 80- to 84-yr-old group, and 17% in the ≥85-yr-old group (20% in the ≥90-yr-old group) (N.S.). The 1- and 5-yr patient survival rates in the ≥85-yr-old group were 90.1% and 48.5% respectively, compared with 86.7% and 60.9% in the 70- to 79-yr-old group and 83.8% and 66.3% in the 80- to 84-yr-old group, respectively (N.S.). CONCLUSION: Despite the management of comorbidities, liver resection for well-selected super elderly patients, such as those aged ≥85 yr included ≥90yr, has acceptable outcomes. The age of patient is not an absolute contraindication to liver resection.
format Online
Article
Text
id pubmed-10334108
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-103341082023-07-12 Efficacy and Safety of Liver Resection in Super Elderly Patients with Hepatocellular Carcinoma Yamamoto, Hidekazu Kaibori, Masaki Matsushima, Hideyuki Kosaka, Hisashi Matsui, Kosuke Sekimoto, Mitsugu Asian Pac J Cancer Prev Research Article OBJECTIVE: Liver resection in the super elderly patients remains challenging because of comorbidities and operative tolerability. METHODS: In this study, we compared postoperative complications and survival in patients aged ≥85 yr included five patients aged ≥90 yr with those aged 70-79 and 80-84 yr at a single institution. RESULTS: Three hundred sixty-seven patients aged ≥70 yr underwent liver resection and were divided into three groups based on age at operation between 2010 and 2022; (a) 70-79 yr (median of 74 yr, n=245), (b) 80-84 yr (median of 82 yr, n=81), and (c) ≥85 yr (median of 87 yr, n=41). In the ≥85 yr group (90-yr-old group), twenty-five patients (four) had hypertension, fourteen (one) had diabetes mellitus, seven (one) had cardiovascular disease, and five patients (one) had dementia. The rate of comorbidities did not differ significantly among three groups. The rate of postoperative complications (Clavien–Dindo grade 3a≤) was 25% in the 70- to 79-yr-old group, 27% in the 80- to 84-yr-old group, and 17% in the ≥85-yr-old group (20% in the ≥90-yr-old group) (N.S.). The 1- and 5-yr patient survival rates in the ≥85-yr-old group were 90.1% and 48.5% respectively, compared with 86.7% and 60.9% in the 70- to 79-yr-old group and 83.8% and 66.3% in the 80- to 84-yr-old group, respectively (N.S.). CONCLUSION: Despite the management of comorbidities, liver resection for well-selected super elderly patients, such as those aged ≥85 yr included ≥90yr, has acceptable outcomes. The age of patient is not an absolute contraindication to liver resection. West Asia Organization for Cancer Prevention 2023 /pmc/articles/PMC10334108/ /pubmed/36974565 http://dx.doi.org/10.31557/APJCP.2023.24.3.1089 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Research Article
Yamamoto, Hidekazu
Kaibori, Masaki
Matsushima, Hideyuki
Kosaka, Hisashi
Matsui, Kosuke
Sekimoto, Mitsugu
Efficacy and Safety of Liver Resection in Super Elderly Patients with Hepatocellular Carcinoma
title Efficacy and Safety of Liver Resection in Super Elderly Patients with Hepatocellular Carcinoma
title_full Efficacy and Safety of Liver Resection in Super Elderly Patients with Hepatocellular Carcinoma
title_fullStr Efficacy and Safety of Liver Resection in Super Elderly Patients with Hepatocellular Carcinoma
title_full_unstemmed Efficacy and Safety of Liver Resection in Super Elderly Patients with Hepatocellular Carcinoma
title_short Efficacy and Safety of Liver Resection in Super Elderly Patients with Hepatocellular Carcinoma
title_sort efficacy and safety of liver resection in super elderly patients with hepatocellular carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334108/
https://www.ncbi.nlm.nih.gov/pubmed/36974565
http://dx.doi.org/10.31557/APJCP.2023.24.3.1089
work_keys_str_mv AT yamamotohidekazu efficacyandsafetyofliverresectioninsuperelderlypatientswithhepatocellularcarcinoma
AT kaiborimasaki efficacyandsafetyofliverresectioninsuperelderlypatientswithhepatocellularcarcinoma
AT matsushimahideyuki efficacyandsafetyofliverresectioninsuperelderlypatientswithhepatocellularcarcinoma
AT kosakahisashi efficacyandsafetyofliverresectioninsuperelderlypatientswithhepatocellularcarcinoma
AT matsuikosuke efficacyandsafetyofliverresectioninsuperelderlypatientswithhepatocellularcarcinoma
AT sekimotomitsugu efficacyandsafetyofliverresectioninsuperelderlypatientswithhepatocellularcarcinoma